Name | Number of supported studies | Average coverage | |
---|---|---|---|
neuron | 4 studies | 37% ± 23% | |
glutamatergic neuron | 4 studies | 43% ± 17% | |
GABAergic amacrine cell | 3 studies | 28% ± 6% | |
GABAergic neuron | 3 studies | 41% ± 11% | |
interneuron | 3 studies | 47% ± 24% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 32% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 77% | 717.09 | 2026 / 2642 | 60% | 4.30 | 420 / 705 |
kidney | 90% | 153.22 | 80 / 89 | 1% | 0.01 | 8 / 901 |
uterus | 69% | 73.88 | 117 / 170 | 4% | 0.11 | 18 / 459 |
ovary | 61% | 57.36 | 109 / 180 | 10% | 0.35 | 44 / 430 |
prostate | 53% | 66.65 | 131 / 245 | 10% | 0.63 | 51 / 502 |
bladder | 43% | 71.57 | 9 / 21 | 12% | 0.40 | 61 / 504 |
adipose | 26% | 23.66 | 316 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 15% | 9.98 | 49 / 328 | 10% | 0.30 | 18 / 178 |
stomach | 21% | 13.38 | 74 / 359 | 2% | 0.06 | 6 / 286 |
breast | 19% | 14.83 | 89 / 459 | 2% | 0.05 | 23 / 1118 |
thymus | 7% | 5.28 | 45 / 653 | 15% | 0.32 | 88 / 605 |
adrenal gland | 3% | 1.72 | 8 / 258 | 8% | 0.41 | 19 / 230 |
intestine | 10% | 5.49 | 94 / 966 | 1% | 0.02 | 4 / 527 |
lung | 6% | 4.13 | 34 / 578 | 3% | 0.09 | 31 / 1155 |
blood vessel | 6% | 4.92 | 86 / 1335 | 0% | 0 | 0 / 0 |
skin | 4% | 2.14 | 68 / 1809 | 1% | 0.02 | 3 / 472 |
esophagus | 2% | 1.51 | 24 / 1445 | 1% | 0.03 | 2 / 183 |
liver | 0% | 0 | 0 / 226 | 2% | 0.03 | 7 / 406 |
heart | 1% | 0.48 | 7 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.34 | 6 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046545 | Biological process | development of primary female sexual characteristics |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | DACH2 |
Protein name | Dachshund family transcription factor 2 DACH2 protein Dachshund homolog 2 (Dach2) |
Synonyms | |
Description | FUNCTION: Transcription factor that is involved in regulation of organogenesis. Seems to be a regulator for SIX1 and SIX6. Seems to act as a corepressor of SIX6 in regulating proliferation by directly repressing cyclin-dependent kinase inhibitors, including the p27Kip1 promoter. Is recruited with SIX6 to the p27Kip1 promoter in embryonal retina. SIX6 corepression seems also to involve NCOR1, TBL1, HDAC1 and HDAC3. May be involved together with PAX3, SIX1, and EYA2 in regulation of myogenesis. In the developing somite, expression of DACH2 and PAX3 is regulated by the overlying ectoderm, and DACH2 and PAX3 positively regulate each other's expression (By similarity). Probably binds to DNA via its DACHbox-N domain. . |
Accessions | D6REJ4 ENST00000373125.9 [Q96NX9-1] ENST00000373131.5 [Q96NX9-2] Q1RMF5 ENST00000484479.1 ENST00000510272.5 [Q96NX9-3] ENST00000506327.6 ENST00000508860.5 [Q96NX9-4] D6RFG7 ENST00000461604.6 Q96NX9 H0Y912 |